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The Role of Parental Cognitive, Behavioral,
andMotor Profiles in Clinical Variability in Individuals
With Chromosome 16p11.2 Deletions
Andres Moreno-De-Luca, MD; DavidW. Evans, PhD; K. B. Boomer, PhD; Ellen Hanson, PhD; Raphael Bernier, PhD;
Robin P. Goin-Kochel, PhD; Scott M. Myers, MD; Thomas D. Challman, MD; Daniel Moreno-De-Luca, MD;
Mylissa M. Slane, MS; Abby E. Hare, PhD;Wendy K. Chung, MD; John E. Spiro, PhD; W. Andrew Faucett, MS;
Christa L. Martin, PhD; David H. Ledbetter, PhD
IMPORTANCE Most disorders caused by copy number variants (CNVs) display significant
clinical variability, often referred to as incomplete penetrance and variable expressivity.
Genetic and environmental sources of this variability are not well understood.
OBJECTIVES To investigate the contributors to phenotypic variability in probands with CNVs
involving the same genomic region; to measure the effect size for de novomutation events;
and to explore the contribution of familial background to resulting cognitive, behavioral, and
motor performance outcomes in probands with de novo CNVs.
DESIGN, SETTING, AND PARTICIPANTS Family-based study designwith a volunteer sample of
56 individuals with de novo 16p11.2 deletions and their noncarrier parents and siblings from
the Simons Variation in Individuals Project.
MAIN OUTCOMES ANDMEASURES We used linear mixed-model analysis tomeasure effect size
and intraclass correlation to determine the influence of family background for a de novo CNV
on quantitative traits representing the following 3 neurodevelopmental domains: cognitive
ability (Full-Scale IQ), social behavior (Social Responsiveness Scale), and neuromotor
performance (Purdue Pegboard Test). We included an anthropometric trait, bodymass index,
for comparison.
RESULTS A significant deleterious effect of the 16p11.2 deletion was demonstrated across all
domains. Relative to the biparental mean, the effect sizes were −1.7 SD for cognitive ability,
2.2 SD for social behavior, and −1.3 SD for neuromotor performance (P < .001). Despite large
deleterious effects, significant positive correlations between parents and probands were
preserved for the Full-Scale IQ (0.42 [P = .03]), the verbal IQ (0.53 [P = .004]), and the Social
Responsiveness Scale (0.52 [P = .009]) scores. We also observed a 1-SD increase in the body
mass index of probands compared with siblings, with an intraclass correlation of 0.40
(P = .07).
CONCLUSIONS AND RELEVANCE Analysis of families with de novo CNVs provides the least
confounded estimate of the effect size of the 16p11.2 deletion on heritable, quantitative traits
and demonstrates a 1- to 2-SD effect across all neurodevelopmental dimensions. Significant
parent-proband correlations indicate that family background contributes to the phenotypic
variability seen in this and perhaps other CNV disorders andmay have implications for
counseling families regarding their children’s developmental and psychiatric prognoses. Use
of biparental mean scores rather than general populationmean scores may bemore relevant
to examine the effect of a mutation or any other cause of trait variation on a
neurodevelopmental outcome and possibly on systems of diagnosis and trait ascertainment
for developmental disorders.
JAMA Psychiatry. 2015;72(2):119-126. doi:10.1001/jamapsychiatry.2014.2147
Published online December 10, 2014.
Editorial page 106
Supplemental content at
jamapsychiatry.com
Author Affiliations:Author
affiliations are listed at the end of this
article.
Corresponding Author:David H.
Ledbetter, PhD, Autism and
Developmental Medicine Institute,
Geisinger Health System, 100 N
Academy Ave, Mail Code 22-01,
Danville, PA 17822 (dhledbetter
@geisinger.edu).
Research
Original Investigation
(Reprinted) 119
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/psych/932731/ by a BUCKNELL UNIVERSITY User  on 01/31/2017
Copyright 2015 American Medical Association. All rights reserved.
T he recurrent deletion between break points 4 and 5 onchromosome 16p11.2 (chr16: 29.5-30.1) is approxi-mately600kilobases long, includes29genes, and isgen-
eratedbynonallelichomologousrecombinationbetweenflank-
ing segmental duplications. The deletion is one of the most
common pathogenic copy number variants (CNVs) and is as-
sociatedwith a broad range of neurodevelopmental and neu-
ropsychiatric diagnoses, including developmental delay, in-
tellectual disability, autism, and schizophrenia, among
others.1-4 In addition to the broad range of the clinical diag-
noses in individuals who carry the deletion (ie, carriers), the
16p11.2 deletion has also been reported in apparently healthy
individuals, a finding frequently interpretedas evidenceof in-
complete penetrance.1,5 In a study of more than 100 000 ap-
parentlyunaffectedcontrolparticipants fromthegeneralpopu-
lationof Iceland, 43 individualswith the 16p11.2deletionwere
identified. However, the individuals with this CNV exhibited
a variety of cognitive andneuropsychological deficits despite
the fact thatnonereachedtraditional clinicaldiagnostic thresh-
olds for aneurodevelopmentalor aneuropsychiatricdisorder.6
A report on 101 individualswith the 16p11.2deletionnoted
that the Full-Scale IQ (FSIQ) score was 2 SD lower in deletion
carriers compared with their relatives who did not carry the
deletion (ie, noncarriers).4 Approximately 15% of the pro-
bands met clinical criteria for autism spectrum disorders. In
more recentwork,Hansonet al7 studied80probandswith the
16p11.2deletionusinganextensivebatteryof assessments.Al-
though only 23% of the probands were diagnosed as having
an intellectual disability or borderline intellectual function-
ing, mean IQ scores were 26 points (1.8 SDs) lower than those
of noncarrier familymembers. Although only 25%of the pro-
bands met full clinical criteria for autism, a significant effect
on social functioning (asmeasured by the Social Responsive-
nessScale [SRS]8)was identifiedasa 1.6-SDshift towardgreater
impairment in probands compared with noncarrier family
members.7 In addition, individuals with the 16p11.2 deletion
showedahigh frequency (>95%)of avarietyofpsychiatric and
developmental categorical diagnoses. Altogether, these data
indicate high penetrance for the clinically significant cogni-
tive, behavioral, and psychiatric impact of the deletion.
Such findings raise important questions as to what ac-
counts for the clinical heterogeneityof this andotherCNVdis-
orders. The clinical manifestations of most genetic disorders
are highly variable, even when considering mendelian dis-
eases. For such single-gene disorders, clinical variabilitymay
be attributed to variation in (1) the specificmutation type and
severity, (2) theexpressionof the remainingwild-typeallele(s),
(3) other loci constituting thegeneticbackground, and (4)non-
genetic environmental exposures during the life course.
Significant clinical variability is also the rule rather than
the exception for classic chromosomal disorders, such as tri-
somy21 (Downsyndrome)andsexchromosomevariations.For
disorders involvinganeuploidy, incontrast tomonogenicmen-
deliandiseases, themutation itself (anextraor amissing chro-
mosome) is identical across cases, so genetic contributions to
clinical variabilitymust bedue tovariable expressionof genes
on the involved chromosome(s), must reflect genetic back-
ground effects, or both.
Many of the traits that constitute the phenotypes of ge-
netic syndromes are distributed continuously in the general
population, and trait variabilitymay be greatly influenced by
the parental genetic background. For example, approxi-
mately 90% of the trait variability for height and 30% to 70%
for cognitive ability are accounted for by the parental genetic
background.9,10 For some psychometric and anthropometric
quantitative traits (cognitive ability, height, head circumfer-
ence,andbodymass index [BMI]), thebestpredictorof theout-
come of an individual from the general population is the bi-
parentalmeanvalue for such traits,with correlations typically
ranging from approximately0.20 to0.70.10 Social behavior, as
measured by the SRS, also demonstrates high heritability (an
approximate heritability estimate of 0.75), with parent-child
correlations of 0.50.11
We hypothesize that such parent-child relationships will
bepreserved inCNVdisorders, suchas 16p11.2deletions. Simi-
lar to aneuploidy syndromes in which the genetic abnormal-
ity is identical for all probands, the functional consequenceof
recurrentCNVs is essentially identical across casesbecause the
break points lie within repetitive regions of the genome, and
thegenes included in the interveningdeletedorduplicated re-
gion are constant. Therefore, for recurrent CNVs, the genetic
contribution to clinical variability shouldbeexplainedbyvari-
able expression of the genes in the CNV interval and/or other
loci constituting the genetic background.
In this study,weexaminedthecognitive,10,12 social,13,14 and
motor15,16 profiles in 56 individuals with de novo deletions of
chromosome 16p11.2 and their noncarrier parents and sib-
lings. We also included BMI, an anthropometric trait that is
highlyheritable andknowntobe increased in individualswith
16p11.2 deletions.17,18 We predicted that this quantitative ap-
proachwould reveal a consistentdeleterious impact of 16p11.2
deletions, even in cases in which clinical diagnostic thresh-
olds were not met. Consistent with previous work on indi-
vidualswith chromosomal aneuploidy19-24 and theCNVasso-
ciated with Prader-Willi syndrome,25 we predicted that the
shared variance observed among first-degree relatives in the
general population would be preserved in families of pro-
bands with de novo 16p11.2 deletions.
Methods
Participants
The studywas approved by the institutional review boards at
each of the following 3 Simons Variations in Individuals Proj-
ectphenotypingsites:BostonChildren’sHospital,Boston,Mas-
sachusetts; Baylor College of Medicine, Houston, Texas; and
University of Washington, Seattle. All participants provided
written informed consent before data collection.
Weobtaineddata from the SimonsVariation in Individuals
Project, which includes a large number of individuals with the
samerecurrentbreakpoint4to516p11.2deletionandtheir fami-
lies. This study contains deidentified comprehensive pheno-
typic data for probands, their parents, and their siblings. De-
tailsonrecruitmentstrategy, theinclusionandexclusioncriteria,
thegenotypingandphenotypingtoolsused,andpoliciesfordata
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collection and sharing have been reported previously.7,26 The
analysesreportedherein include56probands(≥2yearsold)with
a de novo 16p11.2 deletion, their noncarrier biological parents,
and a noncarrier biological sibling closest in age to the pro-
band. A subset of these families have been described in prior
studies.4,7 The analyses were limited to de novo cases to avoid
potential confounding sources of variance associated with in-
herited disorders, such as assortativemating, in an effort to ac-
curately measure the effect size of the CNV and the influence
of the family background on a range of heritable traits.
Measures
Complete familydatavarieddependingonthemeasure, result-
ing in the following sample sizes: 52 dyads for FSIQ and verbal
IQ(VIQ);54dyadsfornonverbal IQ(NVIQ);44dyadsfor theSRS;
and 46 dyads for the Purdue Pegboard Test (PPT)27 (47 for the
dominant hand). Because BMI is highly age dependent, com-
parisonsofBMI z scoreswereperformedonprobandsand their
siblings whowere at least 2 years of age (36 dyads).
We assessed IQ with the Wechsler Abbreviated Scale of
Intelligence,28 the Differential Ability Scales,29 or the Mullen
Scales of Early Learning,30 depending on age and develop-
mental functioning. We used the FSIQ, VIQ, and NVIQ in the
analyses (mean [SD] scores, 100 [15]).
TheSRS is a65-item,quantitativeparent-reportedor adult
self-reported measure that assesses social impairment asso-
ciated with autism spectrum disorders.8 The SRS is sensitive
to subclinical social impairment. Raw scores (mean [SD], 30
[20]) were used to provide greater differentiation of scores at
the lower and higher ends of the scales.
ThePPTmeasures fineandgrossmotordexterityandhand,
finger, andarmcoordination.27 Participants arepresentedwith
a board with 4 cups filled with pins across the top and 2 ver-
tical rowsof 25holes down the center. Theparticipants are in-
structed toplaceasmanypinsaspossible (in30seconds)down
the row on the side of their dominant hand, then the side of
their nondominant hand, and then the sides of both hands si-
multaneously, yielding separate scores for the dominant, the
nondominant, andbothhandsandgenerating standard scores
(mean [SD], 50 [10]) for each variable.
We calculated BMI by dividing the weight (in kilograms)
by the square of the height (in meters) for each age. The BMI
was then converted to a z score.
Statistical Analysis
Analyses were performed using commercially available soft-
ware (SPSS, version 20; IBM). We performed linear mixed-
model (LMM) analyses with unstructured covariance within
the family, allowing the variance-covariance to differ among
the proband, sibling, and parent within a family. Multiple
comparisons were adjusted with Bonferroni methods in the
presence of a significant overall family effect within the
LMM. We examined the differences between the probands’
observed and expected scores (ie, parent scores) using paired
t tests (when only 1 parent was available [13 families], the
available parent’s data were used instead of the biparental
mean). As recommended, we covaried for the SRS score in
the LMM for IQ comparisons, and we covaried for the IQ
scores in the LMM for SRS comparisons.31,32 Sex was not
included as a factor in the LMM because no sex could be
assigned to the biparental values. However, independent t
tests revealed no significant difference in the mean response
(FSIQ, VIQ, NVIQ, SRS, or PPT scores) owing to sex for the
probands or the siblings. We used the intraclass correlation
(ICC) to examine proband-parent correlations.
Results
FSIQ, VIQ, and NVIQ
WeusedLMManalysis toexamine themeandifferencesamong
family members for FSIQ, VIQ, and NVIQ, controlling for the
SRSscore;we foundnosignificant interactionbetween theSRS
score and the familymember for these 3 outcomes. The LMM
analysis revealedstatistically significantdifferences in theFSIQ
scoresamong theproband, sibling, andbiparentalmeanscores
(F2,56.42 = 22.33 [P < .001]) and an SRS effect (F1,104.11 = 8.26
[P = .005]) (Table 1). The proband mean FSIQ score was sig-
nificantly lower than theparental andsiblingmeanFSIQscores
(P < .001). Themeandifference inproband-parentFSIQ scores
(mean [SD], 25.53 [15.09] for 52 pairs) revealed a 1.7-SDdelete-
rious impact basedon standardized IQnorms (Figure 1A). The
siblingFSIQscore alsodiffered fromthebiparentalmeanscore
(P = .04), although to a smaller degree than for probands.
Differences emerged among family members on the VIQ
scores (F2,52.53 19.91 [P < .001]; SRS effect, F1,102.86 = 6.52
[P = .01]).Mean scores for the probands differed significantly
from those for the parents and siblings (P < .001). The mean
difference between the proband and the parent VIQ scores
(mean [SD], −24.63 [15.77] for 52 pairs) showed a 1.6-SD effect
size for the deletion.
The analysis for theNVIQ score (F2,50.65 = 19.97 [P < .001])
also revealed the cognitive impact of de novo 16p11.2 dele-
tions, with the scores for the probands differing significantly
fromthose for theparents (P < .001) and siblings (P = .01); fur-
thermore, the scores for the siblingsweredifferent fromthose
for theparents (P = .001), but to a lesser extent than the scores
for the probands. Accounting for the SRS score revealed an
overall linear effect of the SRSon theNVIQ score (P = .01). The
meandifferencebetween the scores for theprobands andpar-
ents (mean [SD], −25.08 [18.55] for 54 pairs) indicated a del-
eterious effect size of 1.7 SD in the NVIQ.
As noted above, in typical families, parent-child IQ corre-
lations range from approximately0.30to approximately0.70.10
For the parent-proband dyads, the ICC for themean FSIQ ap-
proached thatobserved in thegeneralpopulation (ICC51 = 0.42
[P = .03]); similar results were observed for the VIQ score
(ICC51 = 0.53; [P = .004]). The NVIQ score correlation did not
reach statistical significance (ICC53 = 0.20 [21]) (Table 1).
Despite the shift in the mean IQ of the probands relative
to the parents, the typical parent-child IQ correlation that is
observed in the general population is largely preserved, indi-
cating a significant role for parental background in determin-
ing the cognitive performance of a child with the 16p11.2 de-
letion.Theexceptionwas theNVIQ,which is lessheritable than
the VIQ or the FSIQ in the typical population.33
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Social Responsiveness Scale
Significant differences emerged among first-degree relatives
on social behavior, measured by the SRS (F2,50 = 24.17
[P < .001]), controlling for the FSIQ score (F1,112.32 = 4.39
[P = .04]). Themean SRS score for probands differed from the
scores for parents and siblings (P < .001), but those for par-
ents and siblings did not differ from each other. The proband-
parent difference (mean [SD], 43.90 [29.44] for 44 pairs) indi-
cates a 2.2-SD effect size for the deletion (Figure 1B). As with
the IQ scores, the SRS scores were also highly and positively
correlated between the probands and their parents
(ICC43 = 0.52 [P = .009]), indicating an important contribu-
tion of parental social functioning to a proband’s perfor-
mance level. Although not part of our primary analysis for
this report, significant parent-proband correlations were also
observed for other adaptive and maladaptive behaviors as
indicated by components of the Vineland Adaptive Behavior
Scales34 and the Child Behavior Checklist35 (eTable in the
Supplement).
Purdue Pegboard Test
For the PPT score on the dominant hand, the LMM analysis
revealed differences among family members (F2,46.47 = 12.43
[P < .001]); the proband-parent (P < .001) and proband-
sibling (P = .01) differences were significant. The proband-
parent difference (mean [SD], −13.34 [18.05]) was signifi-
cantly greater than the sibling-parent difference and revealed
a 1.3-SD effect size. For the PPT score for the nondominant
hand, the LMM finding was also significant (F2,49.32 = 10.79
[P < .001]), with differences between the proband and the
biparental and sibling means (P < .001 for both), revealing a
1.3-SD effect size. The PPT scores for both hands also
revealed significant differences among probands, siblings,
and biparental means (F2,49.04 = 15.43 [P < .001]), with a
1.3-SD effect size relative to those of the parents (for 46 pairs)
(Figure 1C). The correlation comparing parent-proband
scores for both hands was in the expected direction but did
not reach statistical significance (ICC45 = 0.21 [P = .22])
(Table 1).
BodyMass Index
Proband and sibling BMI z scores differed significantly
(F1,47.71 = 19.25 [P < .001]), controlling for a significant inter-
action of age by familymember (F1,65.64 = 0.85 [P = .36]). The
meanpaireddifferencebetween theproband (mean [SD], 1.22
[1.16]) and the sibling (mean [SD], 0.26 [0.97]) BMI z scorewas
0.98 (SD, 1.36) or a 1-SD effect size toward a higher BMI (for 36
proband-siblingpairs). The correlationof theprobandandsib-
lingBMIzscoreapproachedsignificance (ICC35 = 0.40[P = .07])
(Figure 1D).
Discussion
The recurrent 16p11.2 deletion is one of the most common
pathogenic CNVs and is associated with a broad range of neu-
rodevelopmental and neuropsychiatric disorders.1-4 In this
study, we investigated the effect size of the 16p11.2 deletion
in de novo cases from a subset of the Simons Variations in
Individuals Project cohort.7 We examined quantitative trait
measures for cognitive, social, motor, and anthropometric
traits with known heritability to understand the contribution
of family background to the phenotypic variability of this
CNV.
Relative to first-degree familymembers, the effect size of
thedenovo 16p11.2 deletion ranged from1.0 to 2.2 SDonmea-
sures of cognitive, social, andmotor performance andonBMI
(Figure 1 andeTable in theSupplement). The largest effectwas
Table 1. Descriptive Statistics for Probands, Siblings, and Biparental Mean Scores on 4Quantitative Traits
Domain
Proband Dataa Sibling Data Biparental Data
ICC P ValueMean (SD)
No. of
Participants Mean (SD)
No. of
Participants Mean (SD)
No. of
Participants
Cognitive
FSIQ score 86 (15) 54 106 (10) 38 112 (10) 54 0.42 .03
VIQ score 83 (17) 54 106 (11) 38 108 (9) 54 0.53 .004
NVIQ score 88 (17) 54 105 (11) 38 114 (10) 54 0.20 .21
Behavioral
SRS score 75 (33) 47 24 (25) 33 30 (18) 51 0.52 .009
Neuromotor
PPT score, DH 30 (16) 48 39 (12) 33 43 (9) 53 0.17 .27
PPT score, NDH 29 (16) 47 40 (12) 33 41 (10) 53 0.01 .81
PPT score, BH 30 (16) 47 43 (10) 33 42 (9) 53 0.21 .22
Anthropometric
BMI z scoreb 1.22 (1.16) 56 0.26 (0.97) 36 NA NA 0.40c .07
Abbreviations: BH, both hands; BMI, bodymass index (calculated as the weight
in kilograms divided by the square of the height in meters); DH, dominant hand;
FSIQ, Full-Scale IQ; ICC, intraclass correlation; NA, not applicable;
NDH, nondominant hand; NVIQ; nonverbal IQ; PPT, Purdue Pegboard Test;
SRS, Social Responsiveness Scale; VIQ, verbal IQ.
a These sample sizes are based on total participants for each group. The linear
mixed-model comparisons and ICC in the results reflect only those data for
whichmatched samples of probands and first-degree relatives are available.
bBecause BMI is highly age dependent, BMI z score comparisons were
performed on probands and their siblings as opposed to their parents.
c Indicates the ICC for the BMI in probands with siblings.
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on behavioral and cognitive domains, followed bymotor per-
formance and BMI. In all domains, probands showed delete-
rious effects relative to expectedoutcomes given thebiparen-
tal mean values.
Evidence of the parental influence on the phenotype re-
sulting from a de novo 16p11.2 deletion is represented by sig-
nificant ICCsbetween theparents (or the siblings) and thepro-
bands on key phenotypic features of this syndrome (Table 1
andeTable in theSupplement).Thesecorrelations indicate that
the observed shifts from the expectedphenotype are not ran-
dombut rather are tied closely to familial background and in-
fluenced by parental traits, as is the case in the general popu-
lation. Formost of the traits, the parent-proband correlations
were nearly identical to those observed in the general popu-
lation.Given thehighheritability for eachof these traits, a sig-
nificant portionof theparental influence is likely owing to ge-
netic background. Thenature of the associations between the
biparental (or sibling in the caseofBMI) and theprobandmean
scores was found to be linear, with slope values ranging from
0.3844x (IQ) to 0.6656x (SRS) (eFigure in the Supplement). As
seen in the general population, amarkedphenotypic variabil-
ity still exists for each individual, and parental cognitive, be-
havioral, and motor performances are not perfect predictors
of the child’s status. However, these findings raise the possi-
bility thatwhen the effect of aCNVonvarious aspects of brain
function is known, assessment of parental phenotypemay al-
lowmore accurate prediction of the expected range of perfor-
mance or the risk for particular clinical diagnoses in their off-
spring with the CNV.
Our findings emphasize the quantitative nature of clini-
cal expression in neurodevelopmental disorders and support
the recent proposal by Cuthbert and Insel36 to develop and
apply dimensional approaches to mental health research. A
dichotomous all-or-none approach to diagnosis has long
dominated the fields of medical genetics, psychiatry, and
psychology, in which the penetrance of a disorder in a popu-
lation is determined by dichotomizing a quantitative trait and
applying somewhat arbitrary thresholds to classify individu-
als as affected or unaffected. Although such approaches may
appeal to our tendency to adopt simplified heuristics, they
fail to recognize the complexity of a more nuanced, quantita-
tive underlying biological reality. Determining the relative
deleterious impact of genetic variants requires an estimate of
expected outcome, a benchmark representing the actual
potential phenotype, were it not for the genetic variant in
question.37
Figure 1. Distribution of 4 Core Traits in ProbandsWith the De Novo 16p11.2 Deletion and Their Noncarrier FamilyMembers
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The deleterious impact of the deletion and the intraclass correlation (ICC)
between probands and their first-degree relatives is indicated for eachmeasure.
The arrows represent the direction of the shift of the proband’s distributions
relative to biparental and sibling distributions. A, Full-Scale IQ (FSIQ). B, Social
Responsiveness Scale (SRS). C, Purdue Pegboard Test (PPT). D, Bodymass
index (BMI; calculated as the weight in kilograms divided by the square of the
height in meters). We transformed the FSIQ, SRS, PPT, and BMI data into a
normal distribution using commercially available software (NORMDIST function
[x, mean, SD, and cumulative] in Microsoft Excel, version 14.3.9; Microsoft
Corporation). The cumulative was set to false to obtain the height of the
probability density curve.
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In a recent report,37 parental scores on quantitative mea-
sures were used in a model as an estimate of a child’s ex-
pected performance or as a starting point fromwhich the del-
eterious impact of a CNV is subtracted when evaluating the
contribution of that CNV to developmental brain dysfunc-
tion. Herein, we tested thismodel and provided familial data
that illustrate that the variability associatedwith a givenCNV
must be considered in relation to the biparental mean when-
ever heritable quantitative traits are involved. As shown in
Figure 2, probands with the identical CNV all show a delete-
rious effect comparedwith parents and siblings butmayhave
different combinations of clinical diagnoses. In Family 14718
(Figure 2A), the deleterious effect of the deletion on quanti-
tative cognitive andmotor traits results inFSIQandPPTscores
below the diagnostic threshold line, whereas the behavioral
domain performance is still within the reference range. This
patient has clinical diagnoses of intellectual disability andde-
velopmental coordination disorder but not autism. In Family
14747 (Figure 2B), the proband’s cognitive performance is de-
creased comparedwith that of the parents but still within the
reference range,whereas thebehavioral score iswithin the im-
paired range, consistent with this patient’s clinical diagnosis
of autism. InFamily 14795 (Figure2C), theprobandhasaquan-
titativeneurodevelopmentalprofile suggestiveof isolatedmo-
tor deficiency without cognitive or behavioral impairments,
which matches this individual’s diagnosis of developmental
coordination disorder without intellectual disability or au-
tism. The variability of clinical diagnoses in part depends on
the parental cognitive, social, andmotor performance levels.
This dependence indicates that the biparental mean values
rather than the general populationmean valuesmay bemore
appropriate inmeasuring theeffect sizeonneurodevelopmen-
tal outcomes for a given CNV and for predicting the potential
range of outcomes for any individual child.37
Estimating the deleterious impact of genetic mutations
through the assessment of quantitative traits in the context
of familial background has been considered for at least 50
years (Table 2). At least 6 studies report that, although indi-
viduals with Turner syndrome exhibited the expected shorter
stature, the parent-proband correlation for height was con-
served (r range, 0.42-0.84).19-22 Similarly, in Klinefelter syn-
drome, investigators have reported the increased height asso-
ciated with the XXY chromosomal complement while also
noting that the correlation between biparental and child
height that is observed in typical families was preserved
(r = 0.62).19 Moreover, a recent study on 118 individuals with
Klinefelter syndrome23 showed a significant effect of familial
learning disabilities on the proband’s neurodevelopmental
outcomes.
Such findings alsohold true for other traits. Childrenwith
Down syndrome exhibited significant IQ deficits, and yet a
strong correlation with parental IQ was preserved.24 Studies
onPrader-Willi syndrome25alsoshowedthatsignificantparent-
childcorrelationsare retained for IQ (r = 0.33),height (r = 0.52),
and BMI (r = 0.53). Altogether, the data given in the present
study combined with previous reports indicate that, despite
the significant deleterious impact associated with chromo-
somal aneuploidyorCNVs, a proband’s performance levels on
Figure 2. Neurodevelopmental Profiles of 3 Simons Variations
in Individuals Project Families Showing the Deleterious Impact
of the De Novo 16p11.2 Deletion Across Cognitive, Behavioral, andMotor
Streams of Development
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MotorBehavioralCognitive
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As in the general population, the expected profile of the abilities of the
noncarrier siblings (controls) is represented on the left side as a range 2 SDs
above and below the biparental mean. For the probands, the expected
neurodevelopmental profile needs to be adjusted (dotted lines) to account for
the impact of the 16p11.2 deletion and is represented on the right side by a
range 2 SDs above and below the adjustedmean, which was calculated by
subtracting the de novo deletion effect size from the biparental mean score for
each domain (cognitive: 1.7 SDs for the Full-Scale IQ [FSIQ]; behavioral: 2.2 SDs
for the Social Responsiveness Scale [SRS]; andmotor: 1.3 SDs for the Purdue
Pegboard Test [PPT]). The dashed line represents the diagnostic threshold
(depicted here as 2 SDs below themean).
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avariety of quantitative traits is significantly influencedby fa-
milial background.40
The argument that the 16p11.2 deletion represents a
variant with incomplete penetrance is not supported by the
quantitative approach reported herein and previously.3,37
Simply because arbitrary diagnostic thresholds are not met
does not indicate that a particular proband is unaffected or
that a given mutation confers no deleterious impact in some
individuals. Our findings highlight the importance of study-
ing genetically distinct subgroups of individuals with neu-
rodevelopmental disorders relative to their own familial/
genetic background to determine, in a quantitative manner,
the extent to which a given genetic mutation affects all
aspects of development. Limiting the analyses to de novo
cases provides the clearest test of the effect of a CNV on
heritable traits because including inherited cases may in-
troduce other sources of variance, such as assortative mat-
ing and likely the deleterious effect of the ability of the
carrier parent to raise the child and provide a nurturing
environment.
Conclusions
Understanding thedevelopmentalprofilesofpopulationswith
CNVs and single gene mutations relative to family back-
ground requires a multidimensional, quantitative approach.
The resulting informationmay have important clinical utility
in guiding clinical geneticists, neurodevelopmental pediatri-
cians, genetic counselors, and others as theyworkwith fami-
lies to better understand the developmental implications of a
variety of specific genetic mutations.
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Table 2. Summary of Studies Assessing Parental Influence on Height and IQ for Selected Genetic Syndromes
Syndrome
Height IQ
Source
Effect Size,
SD
Correlation,
r Valuea
Effect Size,
SD
Correlation,
r Value
45,X NA 0.84 NA NA Lemli et al,38 1963
45,X −3.07 0.84 NA NA Brook et al,39 1974
45,X −4.44 0.61 NA NA Brook et al,19 1977
45,X >−2.00 0.49 NA NA Massa and
Vanderschueren-Lodeweyckx,20 1991
45,X −4.08 0.69 NA NA Holl et al,21 1994
45,X −4.07 0.50 (F),
0.42 (M)
NA NA Rochiccioli et al,22 1994
47,XX+21 −1.87 (F),
−4.86 (M)
0.29 (F),
0.21 (M)
NA NA Brook et al,19 1977
47,XX+21 NA NA −3.17b 0.50 (F),
0.42 (M)
Fraser and Sadovnick,24 1976
47,XX+21 NA NA −5.27c 0.29 (F),
0.69 (M)
Fraser and Sadovnick,24 1976
47,XXY +2.15 0.62 NA NA Brook et al,19 1977
Prader-Willi −0.9 (F),
−1.9 (M)
0.46 (F),
0.54 (M)
−2.9 (F),
−2.8 (M)
0.58 (female),d
0.12 (male)
Malich et al,25 2000
Abbreviations: F, fathers; M, mothers;
NA, not available.
a Indicates proband-parent
correlation.
b Includes home-reared probands.
c Includes institutionalized probands.
d Includes IQ data onmothers only.
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